http://www.exac.com daily 1 2007-11-26T15:37:37Z http://www.exac.com/news/exactech-q3-revenue-42.4m-net-income-2.7m-or-0.21-eps GAINESVILLE, Fla. – October 27, 2009 -- Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today that total revenue for the third quarter of 2009 increased 12% to $42.4 million from $37.9 million in the third quarter of 2008. Diluted earnings per share for the quarter was $0.21 based on net income of $2.7 million. This compares with net income of $2.1 million or $0.16 diluted EPS a year ago. Net income for the quarter, excluding pre-tax legal expenses and costs of $845,000 related to the ongoing Department of Justice (DOJ) inquiry, was $3.3 million or $0.25 EPS. No publisher lnorthsea Press Releases 2009-10-27T20:47:54Z News Item http://www.exac.com/news/exactech-named-as-one-of-americas-200-best-small-companies-by-forbes.com Exactech, Inc. (Nasdaq: EXAC), has been Ranked #188 on the list of America's 200 Best Small Companies published by Forbes.com. No publisher lnorthsea Press Releases 2009-10-22T12:37:06Z News Item http://www.exac.com/news/exactech-announces-q3-earnings-and-conference-call GAINESVILLE, Fla. – Oct 15, 2008 -- Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, will release its third quarter earnings on Tuesday, October 27, after the market closes. No publisher lnorthsea Press Releases 2009-10-15T16:04:33Z News Item http://www.exac.com/news/exactech-team-wins-distinguished-technology-partnership-excellence-award GAINESVILLE, Fla. – September 15, 2009 -- Exactech Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today that the company has earned the Technology Partnership Award of Excellence from the Association for Operations Management (APICS). No publisher lnorthsea Press Releases 2009-09-15T15:35:16Z News Item http://www.exac.com/news/exactech-announces-participation-at-upcoming-healthcare-investor-conferences GAINESVILLE, Fla. -- September 2, 2009 -- Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today that it will be participating at three major healthcare conferences during September. Exactech President David Petty and CFO Jody Phillips will be delivering presentations and meeting with investors at the following conferences: No publisher lnorthsea Press Releases 2009-09-02T18:23:57Z News Item http://www.exac.com/news/exactech-to-present-at-canaccordadams-annual-global-growth-conference-on-august-11 GAINESVILLE, Fla. -- August 10, 2009 -- Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced that Chairman and CEO Bill Petty will present at the CanaccordAdams 29th Annual Global Growth Conference in Boston on Tuesday, August 11 at 4:30 p.m. Eastern Time. No publisher lnorthsea Press Releases 2009-08-11T13:52:26Z News Item http://www.exac.com/news/exactech-q2-revenue-43.3m-net-income-2.6m-or-0.20-eps GAINESVILLE, Fla. -- July 28, 2009 -- Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today that total revenue for the second quarter of 2009 decreased 1% to $43.3 million from $43.7 million in the second quarter of 2008. Diluted earnings per share for the quarter was $0.20 based on net income of $2.6 million. This compares with net income of $3.0 million or $0.24 diluted EPS a year ago. Net income for the quarter, excluding pre-tax legal expenses and costs of $1.2 million related to the ongoing Department of Justice (DOJ) inquiry, was $3.4 million or $0.26 EPS. No publisher lnorthsea Press Releases 2009-07-28T20:31:22Z News Item http://www.exac.com/news/exactech-to-present-at-the-2009-noble-financial-equity-conference-on-june-8 GAINESVILLE, Fla. -- June 1, 2009 -- Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, will present at the Fifth Annual Noble Financial Equity Conference in Hollywood, Florida. The two-day investor conference will showcase 140 small cap public companies. No publisher lnorthsea Press Releases 2009-06-01T14:31:42Z News Item http://www.exac.com/news/exactech-q1-revenue-increases-9-to-43.3-million GAINESVILLE, Fla. -- April 29, 2009 -- Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today revenue of $43.3 million for the first quarter of 2009, a 9% increase over $39.8 million in the first quarter of 2008. Net income was $2.5 million, or $0.19 per diluted share, compared to $2.8 million, or $0.23 per diluted share, in the same quarter a year ago. Net income for the quarter, excluding pre-tax legal expenses and costs of $1.4 million related to the ongoing Department of Justice (DOJ) inquiry, was $3.3 million or $0.26 EPS. No publisher lnorthsea Press Releases 2009-05-04T13:22:06Z News Item http://www.exac.com/news/exactech-schedules-first-quarter-2009-earnings-release-and-conference-call GAINESVILLE, Fla. -- April 23, 2009 -- Exactech, Inc. (Nasdaq: EXAC,), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, will release its first quarter financial results on Wednesday, April 29, 2009 after regular trading hours end. A copy of the earnings release will be available at http://www.hawkassociates.com. No publisher lnorthsea Press Releases 2009-04-23T14:59:29Z News Item http://www.exac.com/news/pro-golfer-peter-jacobsen-endorses-exactech-knee-following-successful-knee-replacement GAINESVILLE, Fla. -- March 12, 2009 -- Exactech, Inc. (Nasdaq: EXAC,), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today that the company has partnered with professional golfer Peter Jacobsen to tell the story of his successful knee replacement with Exactech’s Optetrak® total knee system in 2008. No publisher lnorthsea Press Releases 2009-03-12T19:52:57Z News Item http://www.exac.com/news/exactech-receives-patent-for-rotating-bearing-knee-optetrak-rbk-system GAINESVILLE, Fla. -- February 24, 2009 -- Exactech, Inc. (Nasdaq: EXAC,), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today that is has been issued U.S. Patent 7,422,605,B2 for its rotating bearing knee prosthesis, Optetrak® RBK™. No publisher lnorthsea Press Releases 2009-02-24T18:09:22Z News Item http://www.exac.com/news/exactech-to-present-growth-strategies-at-canaccord-adams-musculoskeletal-conference-in-conjunction-with-aaos-orthopaedic-meeting GAINESVILLE, Fla. -- February 23, 2009 -- Exactech, Inc. (Nasdaq: EXAC,), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, today announced its schedule of future events. No publisher lnorthsea Press Releases 2009-02-23T19:20:25Z News Item http://www.exac.com/news/exactech-extends-knee-development-license-with-hospital-for-special-surgery GAINESVILLE, Fla. -- February 23, 2009 -- Exactech, Inc. (Nasdaq: EXAC,), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today that it has extended its relationship with Hospital for Special Surgery, New York, NY, to further advance implant designs for total knee replacement surgery. Exactech plans to introduce a new knee implant as an evolution of its flagship Optetrak® brand, as a result of this continued collaboration. Limited release of the new knee is expected in the second half of 2009. No publisher lnorthsea Press Releases 2009-02-23T14:47:02Z News Item http://www.exac.com/news/exactech-2008-revenue-up-30-to-162m-net-income-up-31-to-11.1m-eps-0.87 GAINESVILLE, Fla. -- February 18, 2009 -- Exactech, Inc. (Nasdaq: EXAC,), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today that revenue for 2008 increased 30% to $161.7 million from $124.2 million in 2007. Diluted earnings per share for the year was $0.87 based on net income of $11.1 million. This compares with net income of $8.5 million or $0.72 diluted EPS a year ago. Net income for 2008 included pre-tax legal expenses and costs of $2.6 million related to the ongoing Department of Justice (DOJ) inquiry. No publisher lnorthsea Press Releases 2009-02-19T13:25:19Z News Item